NYSE:BRC

Brady Corporation (NYSE: BRC) Reports Strong Q3 Earnings and Robust Financial Health

Font: Financial Modeling Prep  • May 18, 2026

Market Chart
  • Brady Corporation (NYSE: BRC) exceeded Q3 analyst expectations with a record adjusted EPS of $1.50 and revenue of $435.24 million.
  • The company raised its earnings guidance for fiscal year 2026, reflecting strong operational performance and increased net cash from operating activities.
  • Brady Corporation demonstrates robust financial health, characterized by a low Debt-to-Equity ratio of 0.07 and a strong current ratio of 2.01.

Brady Corporation is a global company that manufactures and sells identification and safety products. These items include labels, signs, and software for various industries. The company provides essential products for workplace safety and asset tracking, helping businesses maintain safe and efficient operations.

On May 18, 2026, Brady Corporation announced strong third-quarter results. The company reported earnings per share (EPS) of $1.50, beating analyst estimates of $1.35. This figure represents a record adjusted EPS, marking a 23.0 percent increase from the $1.22 reported in the same quarter last year, as highlighted by GlobeNewswire.

Brady Corporation also surpassed revenue expectations, posting $435.24 million against an estimated $406.07 million. This performance reflects a total sales growth of 13.8 percent for the quarter. The growth was driven by an 8.2 percent increase in organic sales, which is sales from its core operations.

Following the strong results, Brady Corporation raised its earnings guidance for the 2026 fiscal year, as highlighted by Benzinga. The company's operational strength is also seen in its net cash from operating activities. This figure improved to $78.20 million from $59.90 million in the prior year, showing more cash generated from its business.

Brady Corporation shows solid financial health with a low Debt-to-Equity ratio of 0.07, meaning it has very little debt compared to its equity. Its current ratio of 2.01 indicates it has enough short-term assets to cover its short-term liabilities twice over, suggesting good liquidity.

Market Overview
TZA
Direxion Daily Small Cap Bear 3X ETF
$4.83
-7.29%
SLXN
Silexion Therapeutics Ltd.
$0.53
96.95%
HAO
Haoxi Health Technology Limited
$0.01
0.71%
SOXS
Direxion Daily Semiconductor Bear 3X ETF
$8.54
-14.00%
MEHA
Functional Brands, Inc. Common Stock
$0.09
21.95%
JUNS
Jupiter Neurosciences, Inc.
$0.21
-35.94%
PHGE
BiomX Inc.
$0.60
59.60%
WOK
WORK Medical Technology Group Ltd.
$0.19
-19.57%
HCWB
HCW Biologics Inc.
$2.43
129.25%
GDC
GD Culture Group Limited
$0.12
-17.44%